HemoGenyx Pharmaceuticals Plc (HOPHF)
2.33
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
HemoGenyx Pharmaceuticals Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Silence Therapeutics Plc | 43.54M |
| Biodexa Pharmaceuticals Plc | 5.234M |
| NuCana Plc | 12.59M |
| Mereo BioPharma Group Plc | 14.98M |
| Compass Pathways Plc | 112.68M |